Mauna Kea Technologies SA (ALMKT.PA)
- Previous Close
0.4090 - Open
0.4095 - Bid --
- Ask --
- Day's Range
0.4000 - 0.4140 - 52 Week Range
0.3415 - 0.6330 - Volume
146,847 - Avg. Volume
92,934 - Market Cap (intraday)
25.417M - Beta (5Y Monthly) 1.38
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0800 - Earnings Date Apr 25, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.90
Mauna Kea Technologies SA develops and markets medical devices in Europe and internationally. The company offers range of medical devices, which includes gastroenterology, pulmonology, urology, and drug development. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions. The company was incorporated in 2000 and is headquartered in Paris, France.
www.maunakeatech.comRecent News: ALMKT.PA
Performance Overview: ALMKT.PA
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALMKT.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALMKT.PA
Valuation Measures
Market Cap
25.17M
Enterprise Value
47.04M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.42
Price/Book (mrq)
--
Enterprise Value/Revenue
4.47
Enterprise Value/EBITDA
18.22
Financial Highlights
Profitability and Income Statement
Profit Margin
-33.80%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
11.03M
Net Income Avi to Common (ttm)
-3.73M
Diluted EPS (ttm)
-0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: ALMKT.PA
Company Insights: ALMKT.PA
ALMKT.PA does not have Company Insights